Ocular involvement in neonatal herpes simplex virus infection.
D001766:Blindness / Q000209:etiology; D001768:Blister / Q000209:etiology; D002386:Cataract / Q000209:etiology; D002825:Chorioretinitis / Q000209:etiology; D003231:Conjunctivitis / Q000209:etiology; D005128:Eye Diseases / Q000209:etiology; D005132:Eye Manifestations; D005260:Female; D005455:Fluorescent Antibody Technique; D005654:Fundus Oculi; D006566:Herpesviridae Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007231:Infant, Newborn; D007500:Iritis / Q000209:etiology; D007635:Keratitis, Dendritic / Q000209:etiology; D008266:Macula Lutea; D008431:Maternal-Fetal Exchange; D008831:Microcephaly / Q000209:etiology; D009887:Ophthalmoscopy; D011247:Pregnancy; D011680:Pupil / Q000503:physiopathology; D012171:Retinal Vessels; D018139:Simplexvirus / Q000302:isolation & purification
D007065:Idoxuridine